<DOC>
	<DOC>NCT01937767</DOC>
	<brief_summary>This phase II study in patients undergoing elective cardiac surgery will evaluate the efficacy, safety, and pharmacokinetics of remimazolam, compared with propofol and sevoflurane, during the induction and maintenance of general anesthesia.</brief_summary>
	<brief_title>Remimazolam Phase II Cardiac Anesthesia Study</brief_title>
	<detailed_description />
	<mesh_term>Propofol</mesh_term>
	<mesh_term>Remifentanil</mesh_term>
	<mesh_term>Fentanyl</mesh_term>
	<mesh_term>Sevoflurane</mesh_term>
	<mesh_term>Rocuronium</mesh_term>
	<criteria>scheduled for major elective cardiac surgery. scheduled for mechanical ventilation via tracheal intubation. thoracoabdominal replacement of the aorta or other procedure expected to be accompanied by a massive hemorrhage (at least 15% of the circulating blood volume).</criteria>
	<gender>All</gender>
	<minimum_age>18 Years</minimum_age>
	<maximum_age>N/A</maximum_age>
	<verification_date>February 2014</verification_date>
</DOC>